Skip to Main Content

Advertisement

Skip Nav Destination

A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer

Clin Cancer Res (2021) 27 (2): 408–417.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Aditya Mahadevan
  • Brian Warnecke
  • Elaine Chiao
  • Nellie Nafissi
  • Kritisha Parajuli
  • Nejina Rijal
  • Ritesh Parajuli
Cureus (2023)
  • Domenico Iacopetta
  • Jessica Ceramella
  • Noemi Baldino
  • Maria Sinicropi
  • Alessia Catalano
International Journal of Molecular Sciences (2023) 24 (4): 3643.
  • N. N. Babyshkina
  •  I.  A. Uzyanbaev
  •  T.  A. Dronova
  • N. V. Cherdyntseva
Advances in Molecular Oncology (2023) 10 (4): 47.
  • Jiayan Liu
  • Tao Mi
  • Zhaoxia Zhang
  • Liming Jin
  • Maoxian Li
  • Chenghao Zhanghuang
  • Mujie Li
  • Jinkui Wang
  • Xin Wu
  • Zhaoying Wang
  • Xiaojun Tan
  • Zhang Wang
  • Dawei He
European Journal of Pharmacology (2023) 951: 175747.
  • Wenqing Jia
  • Shuyu Luo
  • Han Guo
  • Dexin Kong
Journal of Biomolecular Structure and Dynamics (2023) 41 (17): 8587.
  • Alexandre Bertucci
  • François Bertucci
  • Anthony Gonçalves
Cancers (2023) 15 (5): 1416.
  • L.B. Alves
  • A.C. Moura
  • J. Amorim dos Santos
  • G.A. Borges
  • E.N.S. Guerra
Toxicology in Vitro (2023) 88: 105558.
  • Evie E. M. Kolsteren
  • Esther Deuning-Smit
  • Alanna K. Chu
  • Yvonne C. W. van der Hoeven
  • Judith B. Prins
  • Winette T. A. van der Graaf
  • Carla M. L. van Herpen
  • Inge M. van Oort
  • Sophie Lebel
  • Belinda Thewes
  • Linda Kwakkenbos
  • José A. E. Custers
Cancers (2022) 14 (16): 3889.
  • Yuhan Yue
  • Junqing Liang
  • Yuruo Wu
  • Weibing Tong
  • Dan Li
  • Xuchen Cao
  • Xin Wang
Technology in Cancer Research & Treatment (2022) 21: 153303382211326.
  • Paola Fuso
  • Margherita Muratore
  • Tatiana D’Angelo
  • Ida Paris
  • Luisa Carbognin
  • Giordana Tiberi
  • Francesco Pavese
  • Simona Duranti
  • Armando Orlandi
  • Giampaolo Tortora
  • Giovanni Scambia
  • Alessandra Fabi
Cancers (2022) 14 (9): 2161.
  • K. Van Baelen
  • T. Geukens
  • M. Maetens
  • V. Tjan-Heijnen
  • C.J. Lord
  • S. Linn
  • F.-C. Bidard
  • F. Richard
  • W.W. Yang
  • R.E. Steele
  • S.J. Pettitt
  • C. Van Ongeval
  • M. De Schepper
  • E. Isnaldi
  • I. Nevelsteen
  • A. Smeets
  • K. Punie
  • L. Voorwerk
  • H. Wildiers
  • G. Floris
  • A. Vincent-Salomon
  • P.W.B. Derksen
  • P. Neven
  • E. Senkus
  • E. Sawyer
  • M. Kok
  • C. Desmedt
Annals of Oncology (2022) 33 (8): 769.
  • Aglaia Skolariki
  • Jamie D’Costa
  • Martin Little
  • Simon Lord
Exploration of Targeted Anti-tumor Therapy 172.
  • Yuanyuan He
  • Raimundo Fernandes de Araújo Júnior
  • Luis J. Cruz
  • Christina Eich
Pharmaceutics (2021) 13 (10): 1670.
  • Ajay Dhakal
  • Luna Acharya
  • Ruth O’Regan
  • Shipra Gandhi
  • Carla Falkson
International Journal of Molecular Sciences (2021) 22 (21): 11878.
  • Amy S. Clark
  • Igor Makhlin
  • Angela DeMichele
Clinical Cancer Research (2021) 27 (2): 371.
  • Dwan-Ying Chang
  • Wei-Li Ma
  • Yen-Shen Lu
Therapeutics and Clinical Risk Management (2021) Volume 17: 193.
  • Narmeen S. Rashid
  • Jacqueline M. Grible
  • Charles V. Clevenger
  • J. Chuck Harrell
Clinical & Experimental Metastasis (2021) 38 (3): 263.
  • Fanny Leenhardt
  • Marie Alexandre
  • William Jacot
Expert Opinion on Pharmacotherapy (2021) 22 (6): 667.
Close Modal

or Create an Account

Close Modal
Close Modal